These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10472443)

  • 21. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness.
    Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P
    J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy against human African trypanosomiasis: is there a road to success?
    Burri C
    Parasitology; 2010 Dec; 137(14):1987-94. PubMed ID: 20961469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy of African trypanosomiasis.
    Williamson J
    Trop Dis Bull; 1976 Jul; 73(7):531-42. PubMed ID: 135387
    [No Abstract]   [Full Text] [Related]  

  • 28. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
    Politi C; Carrín G; Evans D; Kuzoe FA; Cattand PD
    Health Econ; 1995; 4(4):273-87. PubMed ID: 8528430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis).
    Blum JA; Burri C; Hatz C; Kazumba L; Mangoni P; Zellweger MJ
    Trop Med Int Health; 2007 Dec; 12(12):1422-32. PubMed ID: 18076548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of human African trypanosomiasis.
    Dumas M; Bouteille B
    Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
    [No Abstract]   [Full Text] [Related]  

  • 32. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.
    Simarro PP; Franco J; Diarra A; Postigo JA; Jannin J
    Parasitology; 2012 Jun; 139(7):842-6. PubMed ID: 22309684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.
    Pépin J; Mpia B
    Emerg Infect Dis; 2005 Jun; 11(6):921-7. PubMed ID: 15963288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis.
    Rhind SG; Sabiston BH; Shek PN; Buguet A; Muanga G; Stanghellini A; Dumas M; Radomski MW
    Clin Immunol Immunopathol; 1997 May; 83(2):185-9. PubMed ID: 9143380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Three patients with African sleeping sickness following a visit to Tanzania].
    Mendonça Melo M; Rasica M; van Thiel PP; Richter C; Kager PA; Wismans PJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2552-6. PubMed ID: 12532670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [2 epidemics of arsenical encephalopathy in the treatment of trypanosomiasis, Uganda, 1992-1993].
    Ancelle T; Barret B; Flachet L; Moren A
    Bull Soc Pathol Exot; 1994; 87(5):341-6. PubMed ID: 7496198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of sleeping-sickness treatment.
    Pécoul B; Gastellu M
    Lancet; 1999 Sep; 354(9182):955-6. PubMed ID: 10489988
    [No Abstract]   [Full Text] [Related]  

  • 40. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
    Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.